YuanDa Pharmaceuticals (00512) introduces the world's first adrenaline nasal spray for treating severe allergic reactions.

Wisdom Finance and Economics APP News, Yuanda Medicine (00512) has announced that recently, the group has reached a product cooperation agreement with Youer Medical Technology (Shanghai) Co., Ltd. (Youer Medicine). The group will obtain exclusive commercial rights for the first adrenaline nasal spray Neffy (Youminsu) in the world for emergency treatment of adult and pediatric patients weighing 30kg and above (2mg size) and pediatric patients weighing 15-30kg (1mg size) with type I allergic reactions (including severe allergic reactions) within the cooperation channels in mainland China, as well as non-exclusive commercial rights in the Hong Kong Special Administrative Region of China. This cooperation is led by the group's subsidiary Yuanda Medicine (Beijing) Co., Ltd. located in Changping District, Beijing, and plans to achieve localization production within 24 months after the product is approved.